Genomate Health Achieves Certification to ISO/IEC 27001:2022 (Information Security)

Cambridge, MA – April 30th, 2025: Genomate Health, a leader in computational reasoning solutions for personalized medicine, has achieved certification to ISO/IEC 27001:2022 for its Information Security Management System (ISMS) covering the development, operation, and maintenance of its precision oncology solutions and services.

‍

Issued by the British Standards Institution (BSI), ISO/IEC 27001:2022 provides a globally recognized framework for establishing, implementing, maintaining, and continually improving an information security management system. This standard helps organizations protect sensitive information, manage risks, and ensure the confidentiality, integrity, and availability of data. In Genomate Health’s case, obtaining this certification underscores its commitment to maintaining the highest levels of data security for patient health information, clinical research data, and partner collaborations. With data privacy and cybersecurity being fundamental to healthcare innovation, this achievement reflects Genomate Health’s proactive approach to managing risk, ensuring regulatory compliance, and fostering trust among patients, oncologists, insurers, pharmaceutical partners, and healthcare systems globally.

‍

Ioana Stupariu, Chief of Staff & Head of Legal at Genomate Health, said:

Certification to ISO/IEC 27001:2022 reflects our dedication to protecting the sensitive information entrusted to us by patients, partners, and healthcare providers. Information security is not just a compliance requirement for us; it is a core pillar of our commitment to advancing precision oncology responsibly and ethically. This milestone demonstrates that we have implemented rigorous controls to safeguard data at every stage of our operations. 

Achieving it is a credit to everyone at Genomate Health and clearly demonstrates our commitment to operational excellence and data protection at the highest standards. The team should be proud of the hard work and discipline that went into building a system that strengthens our ability to serve patients globally, fosters trust with our partners, and positions us for continued innovation and growth.

‍

Going forward, Genomate Health is committed to continually strengthening its operational excellence and will pursue additional industry-recognized certifications, such as the EU-U.S. Data Privacy Framework (EU-U.S. DPF), to ensure its practices remain aligned with the highest standards of security, privacy, and quality management.

‍

About Genomate Health
Genomate Health Inc. is a medical technology company based in Cambridge, MA, developing computational solutions for personalized medicine. Its flagship product, Genomate®, is the first clinically validated universal computational reasoning model to predict response to multiple targeted therapies by analyzing each patient's unique combinations of genetic alterations and biomarkers. Genomate® delivers the first computational reasoning solution to implement the true promise of precision oncology of N-of-1 therapy based on the genomic profile of the patient’s tumor. The result is presented as a comprehensive, data-backed report that guides oncologists and patients toward the most suitable treatment, enhancing the efficacy of therapies. A key contributor to the White House-led CancerX initiative, a graduate of the Mayo Clinic Accelerate Program, and a member of the Precision Medicine Coalition, Genomate Health remains steadfast in its mission to democratize precision oncology worldwide. 

For more information, visit www.genomate.health

‍

About BSI
Since 1901, BSI has been creating an enduring legacy of transformation for the benefit of all. Across all divisions and services, BSI delivers on its purpose by helping its clients to fulfil theirs. For over a century, BSI has driven best practice in organizations around the world and supports a 13,000-strong global community of experts. With extensive expertise in standards, Assurance, Regulatory, and Consulting services, BSI supports organizations to enhance performance, achieve sustainable growth, manage risks, and be a partner in progress.

For more information, please visit: bsigroup.com

‍

Media Contact

Alina Luchian
Marketing & Brand Manager, Genomate Health Inc
alina.luchian(at)genomate.health